search
Back to results

MPP Programming Study

Primary Purpose

Heart Failure

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Hemodynamic measurements for CRT device programming
CRT device implant with MultiPoint Pacing
Sponsored by
Abbott Medical Devices
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Be scheduled to undergo implant of a St. Jude Medical (SJM) CRT-D system with approved standard indication by ESC/EHRA Guidelines
  • Have the ability to provide informed consent for study participation and be willing and able to comply with the Clinical Investigation Plan (CIP) described evaluations and follow-up schedule

Exclusion Criteria:

  • Have high ventricular rate (>90 bpm) during persistent or permanent atrial fibrillation despite available treatment
  • Be in NYHA IV functional class
  • Have a recent myocardial infarction within 40 days prior to enrollment
  • Have undergone cardiac bypass surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures in the following 7 months
  • Have had a recent CVA or TIA within 3 months prior to enrollment
  • Have had intravenous inotropic support in the last 30 days
  • Be less than 18 years of age
  • Be pregnant or planning to become pregnant during the duration of the investigation.

Sites / Locations

  • Maria Cecilia Hospital, GVM Care & Research

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

MultiPoint Pacing programming based on hemodynamics

MultiPoint Pacing programming without hemodynamics

Arm Description

CRT device implant with MultiPoint Pacing Hemodynamic measurements for CRT device programming

CRT device implant with MultiPoint Pacing CRT device programming without hemodynamics

Outcomes

Primary Outcome Measures

end-systolic volume

Secondary Outcome Measures

Full Information

First Posted
May 14, 2013
Last Updated
February 1, 2019
Sponsor
Abbott Medical Devices
search

1. Study Identification

Unique Protocol Identification Number
NCT01856725
Brief Title
MPP Programming Study
Official Title
Evaluation of Programming Strategies for MultiPoint™ Pacing in Cardiac Resynchronization Therapy Patients
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
May 2013 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
February 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Abbott Medical Devices

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare the efficacy of cardiac resynchronization therapy (CRT) device programming with hemodynamic measurements to device programming without hemodynamic measurements.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
MultiPoint Pacing programming based on hemodynamics
Arm Type
Active Comparator
Arm Description
CRT device implant with MultiPoint Pacing Hemodynamic measurements for CRT device programming
Arm Title
MultiPoint Pacing programming without hemodynamics
Arm Type
Experimental
Arm Description
CRT device implant with MultiPoint Pacing CRT device programming without hemodynamics
Intervention Type
Procedure
Intervention Name(s)
Hemodynamic measurements for CRT device programming
Intervention Type
Device
Intervention Name(s)
CRT device implant with MultiPoint Pacing
Primary Outcome Measure Information:
Title
end-systolic volume
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Be scheduled to undergo implant of a St. Jude Medical (SJM) CRT-D system with approved standard indication by ESC/EHRA Guidelines Have the ability to provide informed consent for study participation and be willing and able to comply with the Clinical Investigation Plan (CIP) described evaluations and follow-up schedule Exclusion Criteria: Have high ventricular rate (>90 bpm) during persistent or permanent atrial fibrillation despite available treatment Be in NYHA IV functional class Have a recent myocardial infarction within 40 days prior to enrollment Have undergone cardiac bypass surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures in the following 7 months Have had a recent CVA or TIA within 3 months prior to enrollment Have had intravenous inotropic support in the last 30 days Be less than 18 years of age Be pregnant or planning to become pregnant during the duration of the investigation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlo Pappone, MD, PhD
Organizational Affiliation
Maria Cecilia Hospital, GVM Care & Research
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maria Cecilia Hospital, GVM Care & Research
City
Cotignola
State/Province
RA
ZIP/Postal Code
48010
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

MPP Programming Study

We'll reach out to this number within 24 hrs